WO2004016768A3 - Compositions and methods for inferring ancestry - Google Patents

Compositions and methods for inferring ancestry Download PDF

Info

Publication number
WO2004016768A3
WO2004016768A3 PCT/US2003/026229 US0326229W WO2004016768A3 WO 2004016768 A3 WO2004016768 A3 WO 2004016768A3 US 0326229 W US0326229 W US 0326229W WO 2004016768 A3 WO2004016768 A3 WO 2004016768A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
ancestry
compositions
trait
aims
Prior art date
Application number
PCT/US2003/026229
Other languages
French (fr)
Other versions
WO2004016768A2 (en
Inventor
Tony N Frudakis
Mark D Shriver
Original Assignee
Dnaprint Genomics Inc
Tony N Frudakis
Mark D Shriver
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dnaprint Genomics Inc, Tony N Frudakis, Mark D Shriver filed Critical Dnaprint Genomics Inc
Priority to JP2005502072A priority Critical patent/JP2006514553A/en
Priority to AU2003265572A priority patent/AU2003265572A1/en
Priority to EP03788685A priority patent/EP1578944A4/en
Priority to CA 2496155 priority patent/CA2496155A1/en
Publication of WO2004016768A2 publication Critical patent/WO2004016768A2/en
Publication of WO2004016768A3 publication Critical patent/WO2004016768A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B10/00—ICT specially adapted for evolutionary bioinformatics, e.g. phylogenetic tree construction or analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B45/00—ICT specially adapted for bioinformatics-related data visualisation, e.g. displaying of maps or networks

Abstract

Ancestry informative marker (AIMs) polynucleotides that contain a single nucleotide polymorphism or that contain an insertion or deletion, are provided, as are methods of using panels of the AIMs to draw an inference as to a trait of an individual. The trait can be, for example, biogeographical ancestry, a pigmentation trait, responsiveness to a drug, or susceptibility to a disease. Also provided are methods of determining the proportional ancestry of an individual. Reagents and kits also are provided.
PCT/US2003/026229 2002-08-19 2003-08-19 Compositions and methods for inferring ancestry WO2004016768A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2005502072A JP2006514553A (en) 2002-08-19 2003-08-19 Compositions and methods for inferring ancestry
AU2003265572A AU2003265572A1 (en) 2002-08-19 2003-08-19 Compositions and methods for inferring ancestry
EP03788685A EP1578944A4 (en) 2002-08-19 2003-08-19 Compositions and methods for inferring ancestry
CA 2496155 CA2496155A1 (en) 2002-08-19 2003-08-19 Compositions and methods for inferring ancestry

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US40435702P 2002-08-19 2002-08-19
US60/404,357 2002-08-19
US46761303P 2003-05-02 2003-05-02
US60/467,613 2003-05-02

Publications (2)

Publication Number Publication Date
WO2004016768A2 WO2004016768A2 (en) 2004-02-26
WO2004016768A3 true WO2004016768A3 (en) 2005-12-22

Family

ID=31891429

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/026229 WO2004016768A2 (en) 2002-08-19 2003-08-19 Compositions and methods for inferring ancestry

Country Status (5)

Country Link
EP (1) EP1578944A4 (en)
JP (2) JP2006514553A (en)
AU (2) AU2003265572A1 (en)
CA (1) CA2496155A1 (en)
WO (1) WO2004016768A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1853730A2 (en) * 2005-02-18 2007-11-14 DNAprint Genomics, Inc. Multiplex assays for inferring ancestry
FR2914316A1 (en) * 2006-11-15 2008-10-03 Igna Inst Genetique Nantes Atl METHODS AND TOOLS FOR DETERMINING THE ORIGIN OF A SUBJECT.
FR2910147B1 (en) * 2006-12-19 2009-02-06 Galderma Res & Dev S N C Snc CORRECTIVE METHOD OF PROCESSING RESULTS OF TRANSCRIPTOMIC EXPERIMENTS OBTAINED BY DIFFERENTIAL ANALYSIS
EP2893478A1 (en) * 2012-09-06 2015-07-15 Ancestry.com DNA, LLC Using haplotypes to infer ancestral origins for recently admixed individuals
JP6729678B2 (en) * 2016-02-26 2020-07-22 日本電気株式会社 Information processing apparatus, suspect information generation method and program
CN111061510B (en) * 2019-12-12 2021-01-05 湖南毂梁微电子有限公司 Extensible ASIP structure platform and instruction processing method

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002097047A2 (en) * 2001-05-25 2002-12-05 Dnaprint Genomics, Inc. Compositions and methods for the inference of pigmentation traits
US20030172065A1 (en) * 2001-03-30 2003-09-11 Sorenson James L. System and method for molecular genealogical research

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0008899D0 (en) * 2000-04-11 2000-05-31 Isis Innovation DNA analysis

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030172065A1 (en) * 2001-03-30 2003-09-11 Sorenson James L. System and method for molecular genealogical research
WO2002097047A2 (en) * 2001-05-25 2002-12-05 Dnaprint Genomics, Inc. Compositions and methods for the inference of pigmentation traits

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
CHAKRABORTY R. ET AL.: "Admixture as a tool for finding linked genes and detecting that difference from allelic association between loci.", PNAS, vol. 85, December 1988 (1988-12-01), pages 9119 - 9123, XP002992781 *
CHAKRABORTY R. ET AL.: "'Unique' alleles in admixed populations: a strategy for determining 'hereditary' population differences of disease frequencies.", ETHNICITY & DISEASE., vol. 1, 1991, pages 245 - 256, XP008056101 *
COLLINS-SCHRAMM H. ET AL.: "Ethnic-difference markers for use in mapping by admixture linkage disequilibrium.", AM. J. HUM. GENET., vol. 70, no. 3, 11 March 2002 (2002-03-11), pages 737 - 750, XP002992780 *
DATABASE GENBANK 20 May 2000 (2000-05-20), HATTORI M. ET AL.: "Homo sapiens 98, 305 genomic DNA of 11q23.", XP002992783 *
DATABASE GENBANK 25 July 1997 (1997-07-25), EVANS G. ET AL., XP002992782 *
DRHAM-PIERRE D. ET AL.: "Estimation of carrier frequenca of a 2.7 kb deletion allele of the p gene associated with OCA2 in African-American.", HUM. MUTATION, vol. 7, 1996, pages 370 - 373, XP008056104 *
FERNANDEZ J. ET AL.: "Association of African genetic admixture with resting metabolic rate and abesity among women.", OBESITY RES., vol. 11, no. 7, 7 July 2003 (2003-07-07), pages 904 - 911, XP002992779 *
MCKEIGUE P. ET AL.: "Estimation of admixture and detection of linkage in admixed populations by a Bayesian approach:application to African-American polulations.", ANN. HUM. GENET., vol. 64, no. 2, 2000, pages 171 - 186, XP008056102 *
PARRA E. ET AL.: "Estimating African Americab admixture proportions by use of population-specific alleles.", AM. J. HUM. GENET., vol. 63, 1998, pages 1839 - 1851, XP002310801 *

Also Published As

Publication number Publication date
WO2004016768A2 (en) 2004-02-26
JP2012050432A (en) 2012-03-15
AU2003265572A1 (en) 2004-03-03
EP1578944A4 (en) 2009-12-23
AU2009225275A1 (en) 2009-10-29
EP1578944A2 (en) 2005-09-28
CA2496155A1 (en) 2004-02-26
JP2006514553A (en) 2006-05-11

Similar Documents

Publication Publication Date Title
WO2006089238A3 (en) Multiplex assays for inferring ancestry
WO2004023092A3 (en) Genetic analysis and authentication
WO2004013727A3 (en) Computer systems and methods that use clinical and expression quantitative trait loci to associate genes with traits
WO2001092572A1 (en) Kit and method for determining hla type
WO2000024937A3 (en) Parallel methods for genomic analysis
DE69806003T2 (en) DNA POLYMERASES THAT HAVE IMPROVED ABILITY TO INSTALL MARKED NUCLEOTIDES
WO2002044425A3 (en) Enzymatic nucleic acid synthesis: compositions and methods for altering monomer incorporation fidelity
DE69929542D1 (en) COMPLEXITY MANAGEMENT AND ANALYSIS OF GENOMIC DNA
BR0010616A (en) Nucleic acid sequences to proteins involved in isoprenoid synthesis
WO2004087950A3 (en) Improved system for multi color real time pcr
WO2006010150A3 (en) Housekeeping genes and methods for identifying the same
WO2001090419A3 (en) Methods for genetic analysis of dna to detect sequence variances
MX2007009809A (en) Selection probe amplification.
WO2005035545A3 (en) Single nucleotide polymorphism analysis of highly polymorphic target sequences
HK1147524A1 (en) Oligonucleotides and uses thereof
WO2002086448A3 (en) Detection of microsatellite instability and its use in diagnosis of tumors
AU2001285219A1 (en) Methods and compositions for identifying nucleic acid molecules using nucleolytic activities and hybridization
WO2008070144A3 (en) Imprinted genes and disease
WO2002022879A3 (en) Detection of microsatellite instability and its use in diagnosis of tumors
WO2003083051A3 (en) Multiplex standardized reverse transcriptase-polymerase chain reaction method for assessment of gene expression in small biological samples
WO2004016768A3 (en) Compositions and methods for inferring ancestry
WO2006081353A3 (en) Rapid comparative genome hybridization
AU1204600A (en) Systems and methods for sequencing by hybridization
WO2002040126A3 (en) Methods for identifying nucleotides at defined positions in target nucleic acids using fluorescence polarization
BR9813805A (en) "nucleotide polymorphisms in soy"

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2496155

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2005502072

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2003265572

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2003788685

Country of ref document: EP

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWP Wipo information: published in national office

Ref document number: 2003788685

Country of ref document: EP